1. 1) Uchiyama, M. Progress report of the studies in Japan on eosinophilia-myalgia syndrome caused by L-tryptophan product. Shokuhin Eiseigaku Zasshi (J. Food Hyg. Soc. Japan), 40, 335-355 (1999).
2. 3) Centers for Disease Control and Prevention. Epidemiologic Notes and Reports Eosinophilia-Myalgia Syndrome—New Mexico, MMWR (November 17), 38, 765-767 (1989).
3. 4) Centers for Disease Control and Prevention. Epidemiologic Notes and Reports Eosinophilia-Myalgia Syndrome and L-Tryptophan-Containing Products—New Mexico, Minnesota, Oregon, and New York, MMWR (November 24), 38, 785-788 (1989).
4. 5) Mizutani, T., Mizutani, H., Hashimoto, K., Nakamura, Y., Kishida, M., Taniguchi, H., Murata, M., Kuzuhara, S., Shimizu, M. Simultaneous development of two cases of eosinophilia-myalgia syndrome with the same lot of L-tryptophan in Japan. J. Am. Acad. Dermatol., 25, 512-517 (1991).
5. 6) Mizutani, T., Mizutani, H., Hashimoto, K., Kishida, M., Taniguchi, H., Okada, H., Murata, M., Nakamura, Y., Shimizu, M. Two cases of L-tryptophan ingestion induced induced eosinophilia-myalgia syndrome. Nippon Hifuka Gakkai Zasshi, 101, 561-566 (1991).